Skip to content

Total Assets at other companies

Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$40.87B+8.9%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$99.89M-27.9%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$402.98M-30.5%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$997M-13.8%

Other financials

Income statement

See full
Operating income-$14.9M-49.9%
Net income-$13.7M-190%
EPS (diluted)-$0.15-15.4%

Balance sheet

See full
Cash & equivalents$40.1M+702%
Total debt$834.0K-27.7%
Total equity$240.7M+388%

Cash flow

See full
Operating cash flow-$10.4M-25.5%
CapEx$91.0K+153%
Free cash flow-$10.5M-26.1%

Valuation

See full
Market cap$1.1B+259%
Enterprise value$1.06B+251%

Returns & leverage

See full
Return on equity-30.5%-12.5pp
Debt / equity0.0×
Current ratio19.8×+14.9×

Where this comes from

Reported directly by Corvus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvus Pharmaceuticals's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Corvus Pharmaceuticals's total assets?
Corvus Pharmaceuticals (CRVS) reported total assets of $253.2M in Q1 2026.
How has Corvus Pharmaceuticals's total assets changed year-over-year?
Corvus Pharmaceuticals's total assets increased by 326.0% year-over-year, from $59.44M to $253.2M.
What is the long-term trend for Corvus Pharmaceuticals's total assets?
Over 5 years (2020 to 2025), Corvus Pharmaceuticals's total assets has grown at a -3.6% compound annual growth rate (CAGR), from $85.53M to $71.12M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.